Kewaunee Scientific Corpo... (KEQU)
NASDAQ: KEQU
· Real-Time Price · USD
55.75
-0.75 (-1.33%)
At close: Aug 15, 2025, 12:07 PM
Kewaunee Scientific Revenue Breakdown
| Period Ending | Apr 30, 2025 | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 | Apr 30, 2018 | Apr 30, 2017 | Apr 30, 2016 | Apr 30, 2015 | Apr 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Domestic Operations Revenue | 179.4M | 137.24M | 150.88M | 129.05M | 111.03M | 120.73M | 122.72M | 127.39M | 117.54M | 106.66M | 95.7M | 96.24M |
| Domestic Operations Revenue Growth | +30.72% | -9.04% | +16.92% | +16.22% | -8.03% | -1.62% | -3.67% | +8.38% | +10.21% | +11.45% | -0.56% | n/a |
| International Operations Revenue | 61.07M | 66.52M | 155.38M | 87.57M | 36.43M | 67.15M | 63.26M | 91.02M | 29.17M | 28.89M | 53.88M | 41.29M |
| International Operations Revenue Growth | -8.18% | -57.19% | +77.44% | +140.34% | -45.74% | +6.16% | -30.50% | +212.04% | +0.97% | -46.38% | +30.50% | n/a |
Operating Expense Breakdown
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 15.54M | 16.13M | 9.52M | 9.91M | 9.08M | 8.22M | 40K | 41K | 7.63M | 8.03M | 7.95M | 6.62M | 7.06M | -88K | -89K | -89K | 7M | 288K | 289K | 288K | 6.01M | 7.46M | 6.47M | 6.28M | 6.69M | 5.23M | 5.96M | 5.76M | 6.57M | 5.97M | 5.26M | 5.13M | 5.58M | 4.59M | 4.82M | 5.08M | 4.85M | 4.29M | 3.99M | 4.32M | -3.95M | 3.87M |
| Selling, General, and Administrative Revenue Growth | -3.66% | +69.46% | -3.98% | +9.15% | +10.45% | +20457.50% | -2.44% | -99.46% | -4.96% | +1.01% | +20.05% | -6.22% | -8120.45% | -1.12% | 0.00% | -101.27% | +2331.94% | -0.35% | +0.35% | -95.21% | -19.44% | +15.38% | +2.94% | -6.11% | +27.91% | -12.26% | +3.47% | -12.34% | +10.10% | +13.60% | +2.40% | -8.03% | +21.59% | -4.69% | -5.16% | +4.77% | +13.06% | +7.44% | -7.62% | -209.34% | -202.01% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 920K | n/a | n/a | n/a | 1.01M | n/a | n/a | n/a | 990K | n/a | n/a | n/a | 1.41M | n/a | n/a | n/a | 1.82M | n/a | n/a | n/a | 1.55M | n/a | n/a | n/a | 1.54M | n/a | n/a | n/a | 1.16M | n/a | n/a | n/a | 1.17M | n/a | n/a | n/a | 936K | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a |